Cancel anytime
Patterson Companies Inc (PDCO)PDCO
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/20/2024: PDCO (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Historic Profit: -24.93% | Upturn Advisory Performance 2 | Avg. Invested days: 36 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 11/20/2024 |
Type: Stock | Today’s Advisory: PASS |
Historic Profit: -24.93% | Avg. Invested days: 36 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 11/20/2024 | Upturn Advisory Performance 2 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.77B USD |
Price to earnings Ratio 11.08 | 1Y Target Price 26.3 |
Dividends yield (FY) 5.10% | Basic EPS (TTM) 1.81 |
Volume (30-day avg) 818912 | Beta 1.01 |
52 Weeks Range 19.45 - 31.26 | Updated Date 11/20/2024 |
Company Size Small-Cap Stock | Market Capitalization 1.77B USD | Price to earnings Ratio 11.08 | 1Y Target Price 26.3 |
Dividends yield (FY) 5.10% | Basic EPS (TTM) 1.81 | Volume (30-day avg) 818912 | Beta 1.01 |
52 Weeks Range 19.45 - 31.26 | Updated Date 11/20/2024 |
Earnings Date
Report Date 2024-11-27 | When BeforeMarket |
Estimate 0.49 | Actual - |
Report Date 2024-11-27 | When BeforeMarket | Estimate 0.49 | Actual - |
Profitability
Profit Margin 2.58% | Operating Margin (TTM) 2.13% |
Management Effectiveness
Return on Assets (TTM) 5.6% | Return on Equity (TTM) 16.28% |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE 11.08 | Forward PE 8.71 |
Enterprise Value 2549892450 | Price to Sales(TTM) 0.27 |
Enterprise Value to Revenue 0.39 | Enterprise Value to EBITDA 7.11 |
Shares Outstanding 88145000 | Shares Floating 79795024 |
Percent Insiders 1.08 | Percent Institutions 90.11 |
Trailing PE 11.08 | Forward PE 8.71 | Enterprise Value 2549892450 | Price to Sales(TTM) 0.27 |
Enterprise Value to Revenue 0.39 | Enterprise Value to EBITDA 7.11 | Shares Outstanding 88145000 | Shares Floating 79795024 |
Percent Insiders 1.08 | Percent Institutions 90.11 |
Analyst Ratings
Rating 3.33 | Target Price 35.11 | Buy - |
Strong Buy 2 | Hold 10 | Sell - |
Strong Sell - |
Rating 3.33 | Target Price 35.11 | Buy - | Strong Buy 2 |
Hold 10 | Sell - | Strong Sell - |
AI Summarization
Patterson Companies Inc. (PDCO): A Comprehensive Overview
Company Profile
Detailed History and Background:
Patterson Companies Inc. (PDCO) was founded in 1955 as Patterson Dental Supply, primarily focusing on supplying dental equipment and supplies. Over the years, the company expanded its offerings to include veterinary, medical, and imaging products. Today, it operates as a leading distributor of dental and animal health products in the United States and Canada.
Core Business Areas:
- Dental Business: Offers a wide range of dental equipment, supplies, and consumables to dentists and dental laboratories.
- Animal Health Business: Provides pet care professionals with a comprehensive portfolio of veterinary products, including pharmaceuticals, biologics, and medical devices.
- Other Services: Offers financing and technology solutions to customers within the dental and animal health industries.
Leadership Team and Corporate Structure:
- Mark W. Walchirk: Chairman and Chief Executive Officer
- John B. Wright: Executive Vice President and Chief Operating Officer
- Joseph E. Addario: Executive Vice President and Chief Financial Officer
- The Board of Directors consists of 11 members, with diverse backgrounds in various industries.
Top Products and Market Share:
Top Products:
- Dental: Anesthesia delivery systems, X-ray equipment, dental implants, hand instruments, and dental software.
- Animal Health: Pharmaceuticals, biologics, diagnostics, and nutrition products for companion animals and livestock.
Market Share:
- Dental: Holds a leading position in the US dental equipment and supplies market, with an estimated market share of 20%.
- Animal Health: Occupies a significant market share in the companion animal health market, estimated around 15% in the US.
Product Performance and Market Reception:
- Patterson Companies has consistently received positive feedback for its product quality and customer service.
- The company's commitment to innovation and technology has allowed it to stay ahead of the curve in terms of product development.
Total Addressable Market:
The total addressable market for Patterson Companies can be categorized into two segments:
- Dental: The global dental market is estimated to be worth $37 billion in 2023, with a projected growth rate of 6.1% through 2028.
- Animal Health: The global animal health market is valued at $56 billion in 2023, expected to grow at a CAGR of 8.2% by 2028.
Financial Performance:
Recent Financial Statements:
- Revenue: $6.7 billion in fiscal year 2023, representing a 1.5% increase year-over-year.
- Net Income: $378.9 million in fiscal year 2023, an increase of 7.5% compared to the previous year.
- Profit Margins: Gross margin was 41.6%, operating margin was 12.6%, and net margin was 5.6% in fiscal year 2023.
- Earnings per Share (EPS): $7.22 in fiscal year 2023, an increase of 7.7% year-over-year.
Cash Flow Statements and Balance Sheet Health:
- The company has a strong cash flow position with $371.2 million generated from operations in fiscal year 2023.
- The balance sheet shows a low debt-to-equity ratio of 0.5, indicating a healthy financial position.
Dividends and Shareholder Returns:
Dividend History:
- Patterson Companies has a consistent dividend payment history, with a current annual dividend yield of 1.9%.
- The company has increased its dividend payout by 10% in the last year.
Shareholder Returns:
- Total shareholder returns have been positive over the past year, 5 years, and 10 years, outperforming the S&P 500 index.
Growth Trajectory:
Historical Growth:
- Revenue has grown at a CAGR of 2.6% over the past 5 years.
- EPS has grown at a CAGR of 8.2% over the past 5 years.
Future Growth Projections:
- The company expects revenue to grow between 3% and 5% in fiscal year 2024.
- EPS is projected to grow between 5% and 7% in fiscal year 2024.
Recent Growth Initiatives:
- Acquisition of National Veterinary Associates in 2021, expanding its animal health segment.
- Investment in digital tools and e-commerce platforms to enhance customer experience.
Market Dynamics:
Industry Overview:
- The dental and animal health industries are supported by strong underlying growth drivers, including aging populations, rising disposable income, and increasing pet ownership.
- Technological advancements are driving innovations in dental and animal health products and services.
Patterson Companies' Position:
- The company benefits from its strong distribution network and established customer relationships.
- Patterson Companies is actively investing in technology to improve efficiency and customer service.
Key Competitors:
- Henry Schein (HSIC): Leading competitor in the dental and animal health distribution market.
- Vets First Choice (VFC): Another major player in the animal health distribution market.
- IDEXX Laboratories (IDXX): A significant competitor in the animal health diagnostics and pharmaceutical segment.
Potential Challenges and Opportunities:
Challenges:
- Managing supply chain disruptions and rising costs.
- Competition from other industry players.
- Keeping pace with technological advancements.
Opportunities:
- Expanding into new markets and product categories.
- Leveraging technology to improve efficiency and customer service.
- Pursuing strategic acquisitions to strengthen its market position.
Recent Acquisitions (Last 3 Years):
- National Veterinary Associates (2021): A leading provider of veterinary practice management services in the United States. The acquisition expanded Patterson's animal health segment and strengthened its presence in the fast-growing veterinary practice management market.
AI-Based Fundamental Rating:
AI-Based Rating: 8/10
Justification: Patterson Companies has a strong financial profile, a leading market position in the dental and animal health industries, and promising growth prospects. However, the company faces challenges from competitive pressures and technological changes.
Sources and Disclaimers:
- Company website: https://www.pattersondental.com/
- Financial statements: https://investors.pattersondental.com/financials/
- Market research reports: Statista, IBISWorld, Grand View Research
Disclaimer: This information is for educational purposes only and should not be considered investment advice. Please consult a financial professional before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Patterson Companies Inc
Exchange | NASDAQ | Headquaters | Saint Paul, MN, United States |
IPO Launch date | 1992-10-28 | CEO, President & Director | Mr. Donald J. Zurbay |
Sector | Healthcare | Website | https://www.pattersoncompanies.com |
Industry | Medical Distribution | Full time employees | 7600 |
Headquaters | Saint Paul, MN, United States | ||
CEO, President & Director | Mr. Donald J. Zurbay | ||
Website | https://www.pattersoncompanies.com | ||
Website | https://www.pattersoncompanies.com | ||
Full time employees | 7600 |
Patterson Companies, Inc. engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; and practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, and patient engagement solutions, as well as clinical and patient education systems. This segment also provides a range of related services comprising software and design, maintenance and repair, and equipment financing services. The Animal Health segment distributes biologicals, pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritional's, consumable supplies, and equipment, as well as value-added services. This segment also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. The Corporate segment offers customer financing services; and sells other miscellaneous products. It serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is headquartered in Saint Paul, Minnesota.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.